Mary Charlotte Stephenson1,
1SPMMRC, School of Physics and
Astronomy, University of Nottingham, Nottingham, Nottinghamshire, United
Kingdom; 2Academic Radiology, University of Nottingham,
Nottingham, Nottinghamshire, United Kingdom; 3School of Community
Healthy Sciences, University of Nottingham, Nottingham, Nottinghamshire
Metabolic
profiles in the posterior cingulate cortex (PCC) have been found to be
altered due to healthy aging and in many neurodegenerative diseases. The
purpose of this study was to use increased spectral resolution and signal,
available at higher field, to measure changes in the PCC metabolic profile
due to healthy aging and cognitive impairment. Atrophy corrected levels of
N-acetyl aspartate, glutamate and aspartate were found to significantly
decrease with healthy aging. Levels of phosphocreatine were greatly reduced
in patients with cognitive impairment, supporting a crucial role for Creatine
Kinase dysfunction in dementia.